These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8262115)

  • 1. Quality of life in prostatic carcinoma.
    da Silva FC
    Eur Urol; 1993; 24 Suppl 2():113-7. PubMed ID: 8262115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The quality of life of patients with newly diagnosed M1 prostate cancer: experience with EORTC clinical trial 30853.
    da Silva FC; Fossa SD; Aaronson NK; Serbouti S; Denis L; Casselman J; Whelan P; Hetherington J; Fava C; Richards B; Robinson MR
    Eur J Cancer; 1996 Jan; 32A(1):72-7. PubMed ID: 8695246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center.
    Denis LJ; Carnelro de Moura JL; Bono A; Sylvester R; Whelan P; Newling D; Depauw M
    Urology; 1993 Aug; 42(2):119-29; discussion 129-30. PubMed ID: 8367920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in patients with prostatic cancer. A feasibility study. The Members of Quality of Life Committee of the EORTC Genitourinary Group.
    da Silva FC; Reis E; Costa T; Denis L
    Cancer; 1993 Feb; 71(3 Suppl):1138-42. PubMed ID: 8428336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.
    Iversen P; Suciu S; Sylvester R; Christensen I; Denis L
    Cancer; 1990 Sep; 66(5 Suppl):1067-73. PubMed ID: 2144208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group.
    Cassileth BR; Soloway MS; Vogelzang NJ; Chou JM; Schellhammer PD; Seidmon EJ; Kennealey GT
    Qual Life Res; 1992 Oct; 1(5):323-9. PubMed ID: 1299464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
    Moinpour CM; Savage MJ; Troxel A; Lovato LC; Eisenberger M; Veith RW; Higgins B; Skeel R; Yee M; Blumenstein BA; Crawford ED; Meyskens FL
    J Natl Cancer Inst; 1998 Oct; 90(20):1537-44. PubMed ID: 9790546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer. European Organization for Research and Treatment of Cancer.
    Rosendahl I; Kiebert GM; Curran D; Cole BF; Weeks JC; Denis LJ; Hall RR
    Prostate; 1999 Feb; 38(2):100-9. PubMed ID: 9973095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the European Organization for Research and Treatment of Cancer--Genitourinary Group Study 30853.
    Newling DW; Denis L; Vermeylen K
    Cancer; 1993 Dec; 72(12 Suppl):3793-8. PubMed ID: 8252492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group.
    Keuppens F; Denis L; Smith P; Carvalho AP; Newling D; Bond A; Sylvester R; De Pauw M; Vermeylen K; Ongena P
    Cancer; 1990 Sep; 66(5 Suppl):1045-57. PubMed ID: 2144206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goserelin (Zoladex) or orchiectomy in metastatic prostate cancer? A quality of life and cost-effectiveness analysis.
    Nygård R; Norum J; Due J
    Anticancer Res; 2001; 21(1B):781-8. PubMed ID: 11299844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of Danish Prostatic Cancer Group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer.
    Iversen P; Rasmussen F; Klarskov P; Christensen IJ
    Cancer; 1993 Dec; 72(12 Suppl):3851-4. PubMed ID: 8252502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.
    Denis L; Smith PH; De Moura JL; Newling DW; Bono A; Keuppens F; Robinson M; Mahler C; Sylvester R; De Pauw M
    Eur Urol; 1990; 18 Suppl 3():34-40. PubMed ID: 2151274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatment.
    Robinson MR; Denis L; Newling DW; Sylvester R; De Pauw M
    Cancer; 1990 Sep; 66(5 Suppl):1022-4. PubMed ID: 2144204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853). European Organization for Research and Treatment of Cancer--Genitourinary Group.
    Keuppens F; Whelan P; Carneiro de Moura JL; Newling D; Bono A; Denis L; Robinson M; Mahler C; Sylvester R; De Pauw M
    Cancer; 1993 Dec; 72(12 Suppl):3863-9. PubMed ID: 8252505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment in prostatic cancer.
    Da Silva FC; Aaronson N
    Prog Clin Biol Res; 1988; 260():119-21. PubMed ID: 2966404
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quality of life following endocrine therapy for advanced prostate cancer: a comparative study between LH-RH agonist 1-month depot and 3-month depot].
    Namiki S; Ishidoya S; Saito S; Mitsukawa S; Suzuki Y; Numata I; Arai Y
    Nihon Hinyokika Gakkai Zasshi; 2008 Jul; 99(5):631-7. PubMed ID: 18697469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in prostatic cancer patients.
    da Silva FC
    Cancer; 1993 Dec; 72(12 Suppl):3803-6. PubMed ID: 8252494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
    Tyrrell CJ; Altwein JE; Klippel F; Varenhorst E; Lunglmayr G; Boccardo F; Holdaway IM; Haefliger JM; Jordaan JP
    J Urol; 1991 Nov; 146(5):1321-6. PubMed ID: 1834864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
    Schellhammer P; Sharifi R; Block N; Soloway M; Venner P; Patterson AL; Sarosdy M; Vogelzang N; Jones J; Kolvenbag G
    Urology; 1995 May; 45(5):745-52. PubMed ID: 7538237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.